Arboviruses in Kenya: A Systematic Review and Meta-analysis of Prevalence

Lynn J Kirwa, Hussein M. Abkallo, Richard Nyamota, Enock Kiprono, Dishon Muloi, James Akoko, Jennifer S. Lord, Bernard Bett
doi: https://doi.org/10.1101/2024.10.17.24315511

Abstract

Arboviruses cause >700,000 human deaths annually, with Rift Valley fever (RFV), yellow fever (YF), chikungunya, and dengue outbreaks posing major public health and economic challenges in East Africa. Yet, no comprehensive studies have consolidated Kenya’s historical arboviral data to support risk assessment and inform control strategies. We registered this review in PROSPERO (CRD42023407963) and searched Web of Science, PubMed, and Global Health databases for observational articles reporting prevalence from the three main arboviral families from inception until 15th March 2023. We pooled the IgG prevalence of arboviruses using a random-effects meta-analysis with a generalised linear mixed-effects model. Heterogeneity was assessed and quantified using Cochran’s Q and I2 statistics and 95% prediction intervals estimated. We included 65 articles (246 datapoints; 14 arboviruses) in our analysis. The pooled IgG prevalence of RVF was 16% (95% CI: 11–24%; I²=70%) in wildlife, 10% (95% CI: 8–13%; I²=90%) in livestock, and 7% (95% CI: 4–11%; I²=98%) in humans, with consistently high rates observed in Garissa and Tana River counties. Among Aedes-borne viruses, chikungunya showed the highest prevalence (10%; 95% CI: 4–24%; I²=99%), followed by dengue (6%; 95% CI: 3–11%; I²=98%) and YF (5%; 95% CI: 2–11%; I²=97%), with the highest prevalence in Busia and Kwale. West Nile virus prevalence in humans was also estimated at 9% (95% CI: 5–14%; I²=93%). Overall, the Coast, Western, and Rift Valley regions were the most affected. Multiple arboviruses have historically circulated Kenya, and with the increasing pressures of climate change, urbanization, and global connectivity, the risk of outbreaks, particularly from Aedes-borne viruses, is escalating. Proactive, sustained surveillance as well as integrated public health strategies through a One Health lens are needed to mitigate these threats and protect vulnerable populations.

Author Summary Infections like Rift Valley fever, dengue, chikungunya, yellow fever, and West Nile virus are major neglected tropical diseases that pose significant public health threats both in Kenya and globally. Given the conducive conditions in Kenya and the absence of a comprehensive routine surveillance system, many areas remain under-monitored, increasing the risk of undetected transmission and delayed responses, which leaves vulnerable populations at greater risk. It is therefore imperative to conduct a thorough assessment of baseline prevalence for these diseases through a systematic review and meta-analysis that consolidates and analyses existing evidence for improved public health planning. Our study provides a detailed review of historical IgG prevalence data for 14 of these diseases in Kenya, illustrating their long-standing circulation in human, livestock, and wildlife populations, as well as the heightened risk of outbreaks driven by climate change and urbanization. We emphasize the urgent need for ongoing surveillance and integrated public health strategies tailored to Kenya’s unique context, such as those supported by the GAI initiative, to effectively protect vulnerable populations from future outbreaks, nationally and regionally.

Introduction

Vector-borne diseases constitute approximately 17% of the estimated global burden of infectious diseases and cause >700,000 deaths annually (1,2). Arthropod-borne viruses (arboviruses) contribute substantially to this burden, with dengue virus (DENV) alone responsible for >6.5 million human infections and >7300 deaths in 2023 (3). With severe associated complications like dengue shock syndrome and long-term chikungunya disability, potential epidemiological shifts due to changes in climate and vector distribution, in addition to urbanisation, there is an urgent need for increased arboviral research and management (2,4–7). In response, WHO launched the Global Arbovirus Initiative (GAI) to build a coalition of countries and strategic multisectoral partners, to improve surveillance, prevention, and control through an integrated and coordinated approach for maximum impact in high-burden and at-risk areas (8,9). The GAI‘s first pillar, ’monitor risk and anticipate’ emphasizes developing a robust surveillance system that integrates current and historical data to establish baselines, and mapping risks to identify vulnerable areas. Studies on IgG exposure support these priority actions by contributing to establishing local historical baselines and improving data quality to identify areas at risk, allocate resources efficiently, and formulate innovative targeted mitigation strategies (9).

In Kenya, like many tropical countries, human and animal populations are vulnerable to arboviruses owing to the optimal climate that supports a wide range of vector species able to transmit arboviruses (10). Several arboviruses, both well-established and emerging, including DENV, chikungunya (CHIKV), West Nile (WNV), Rift Valley fever (RVFV), Ngari (NV) and yellow fever (YFV) have been documented in the country (10–13). Furthermore, Kenya’s proximity to countries reporting recurring arboviral outbreaks like Uganda, Sudan, Tanzania, and Somalia may exacerbate the risk of arboviral importation into the country through transboundary movements (14,15)Despite these irrefutable risks, Kenya lacks a comprehensive routine surveillance system to actively monitor arboviral activity across the country for timely intervention (15,16). Existing surveillance efforts in Kenya are reactive, intensifying once outbreaks are underway or through interepidemic investigations, often focusing on high-profile arboviruses and identified hotspots (17). Consequently, large parts of the country may be under-monitored, increasing the potential for undetected transmission and delayed responses, leaving vulnerable populations at greater risk. Considering the healthcare burden they and other vector-borne diseases exert, alongside their impoverishing socioeconomic ramifications (18,19), the urgency for a thorough assessment of their baseline prevalences in the country per WHO-GAIV goals cannot be overemphasised. Here, we report the findings of a systematic review and meta-analysis of IgG seroprevalence in humans, livestock, and wildlife, consolidating and analysing existing evidence on arboviral exposure across Kenya. Given Kenya’s position as a regional trading, transportation and healthcare hub, our findings will contribute to national research and control efforts in addition to regional strategies for arboviral disease mitigation.

Methods

Our systematic review and meta-analysis protocol was registered in advance in the PROSPERO International Prospective Register of Systematic Reviews (CRD42023407963) and was reported according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines (S1 File) (20).

Systematic search of the literature

We conducted a systematic search in PubMed (since 1946), Web of Science (since 1900), and Global Health (since 1973) databases from their inceptions to 15th March 2023. Our search syntax (S2 File) was based on keywords from the Medical Subject Headings (MeSH) database and was designed to capture all published studies reporting prevalence data for arboviral families, including Togaviridae (CHIKV, ONNV, Sindbis virus (SINV)), Flaviviridae (DENV, WNV, YFV, ZIKV, TBEV), Bunyaviridae (Orthobunyavirus, NV, RVFV, CCHFV), and other related viruses in Kenya. All selected articles were collated and uploaded into Rayyan QCRI (21) and filtered for duplicate records.

We considered cross-sectional studies, both community- and hospital-based, before, during and after reported arboviral outbreaks in Kenya. We included studies that reported prevalence of arboviruses in human, livestock and/ or wildlife populations based on serological detection of immunoglobin G or M (IgG, IgM), viral isolation or reverse transcription–polymerase chain reaction (RT-PCR). We excluded all studies conducted outside Kenya, and any comments, conference notes, reviews and meta-analyses, case reports, and non-peer-reviewed manuscripts (21) Two (L.J.K., R.N.) reviewers independently and blindly screened the remaining articles in two stages: primary screening of the titles and abstracts, and secondary screening of full-text articles, recording reasons for exclusions (21). Disagreements were resolved by discussing with two additional independent reviewers (H.A., J.L.).

Evaluation of the quality of studies

Two reviewers (L.J.K., R.N.) independently assessed each included study’s quality using the Joanna Briggs Institute System for the Unified Management, Assessment and Review of Information (JBI SUMARI) critical appraisal tool (S3 File) (22). Specifically, this appraisal was done against nine criteria encompassing elements related to sampling, population representativeness and description, sample size determination, diagnostics coverage and availability, statistical analysis, and addressing low response rates (23). Disagreements were resolved by discussing with two additional independent reviewers (H.A., J.A.). Study quality was scored as high (7-10), moderate (4-6), or low (0-3), with studies rated as high and moderate considered suitable for inclusion in the meta-analysis (24–26).

Data extraction

Three reviewers (L.J.K., R.N., E.K.) extracted data from included studies, to a single predefined summary Excel sheet (S4 File). These data included the first author, publication year, study design, sampling method (probabilistic, non-probabilistic), sample size, arbovirus, study setting (rural, urban, peri-urban), study period, transmission period (during or between outbreaks), geographical location (county, region), population, human participant recruitment (community, health facilities), human clinical status (apparently health, febrile illness), detection assay, confirmatory test if any, and proportion of positives per total numbers tested. In publications reporting seroprevalence studies from more than one arbovirus, population, and/ or geographic locations (counties or regions), each was considered as a separate study/ row of data.

Meta-analysis of prevalence

For each study where IgG data were available, we calculated IgG prevalence estimates and their corresponding 95% confidence intervals using the exact binomial method (28). We then conducted a meta-analysis of prevalence for each arbovirus using R statistical software (version 4.2.0), using the ‘meta’ package. We estimated the pooled prevalence for each arbovirus and host population using a random intercept logistic regression model with a logit link function. The magnitude of heterogeneity between studies was assessed using Cochran’s Q and quantified using the I2 statistic; with an I2 of more than 75% indicating substantial heterogeneity in the studies (27). We estimated 95% prediction intervals to capture the expected range of true proportions, and used forest plots to visualise the results (28). The distribution of arbovirus IgG prevalence across different geographical locations was mapped using QGIS software (version 2.18.26) (31).

Results

Study selection

We retrieved 3085 publications and after removing 1055 duplicates, 2030 were screened by title and abstract. From these, 97 full texts were screened, resulting in 65 articles that met our inclusion criteria (Fig. 1). Thirty-seven of these articles included multiple seroprevalence studies for more than one arbovirus, population, and/or geographic location (counties or regions) and were thus considered separately for analysis, resulting in 246 datapoints. Most studies (85%, 209/246) were of high quality, with 15% (37/246) rated as moderate quality (S5 File).

Fig. 1 Study selection process based on the PRISMA flowchart. Abbreviations: n = number of studies.

Summary of seroprevalence studies

Of the studies, 40.7% (100) reported IgG seroprevalence for RVFV, followed by DENV (15%, 37), WNV (8.9%, 22), CHIKV (8.9%, 22), YFV (6.1%, 15), ZIKV (4.5%, 11), TBEV (4.1%, 10), CCHFV (4.1%, 10), ONNV (2.8%, 7), Sindbis (SINDV) (1.2%, 3), Banzi (BANZV) (1.2%, 3), Bunyamwera (BUNYV) (1.2%, 3247), NV (0.8%, 2), and Orthobunyaviruses (0.4%, 1). Of these studies, 74.8% (n=184) focused on human populations, 14.2% (n=35) included livestock sampling and 11% (27) included wildlife.

Among 184 human population studies, 64.7% (n=119) sampled apparent healthy individuals, while 31.5% (58) sampled those presenting in health facilities with febrile illnesses that were confirmed as arboviruses: DENV (17), WNV (11), TBEV (7), CCHFV (5), CHIKV (5), RVFV (4), YFV (4), ZIKV (4), and Orthobunyaviruses (1). Seven (3.8%) studies were carried out in both settings. Most of the studies were cross-sectional (97.2%, 239), with the remainder being cohort (1.6%, 4) and longitudinal (1.2%, 3). Additionally, 64.2% (158/246) carried out between outbreaks with human participants recruited from either the community (119/184, 64.7%) or health facilities (65/184, 35.3%). All eight regions in Kenya were represented by at least one study (Fig. 2). Coast and Rift Valley regions region had the highest number of studies while Nairobi and Central regions had the least.

Fig. 2 Number of publications reporting seroprevalence estimates by geographical region:

RVFV (A); DENV (B); YFV (C); CHIKV (D). Source: The base map was retrieved from https://data.humdata.org and modified with QGIS software version 3.36.1-Maidenhead.

Of the 246 studies, IgG antibodies were the most tested (41.1%, 101/246), followed by combinations of IgG and IgM (27.6%, 68/246), unspecified antibodies (15.4%, 38/246), IgM and viral RNA (4.9%, 12/246), IgG/IgM (4.5%, 11/246), IgG/IgM and viral RNA (1.2%, 3/246), IgA, IgM, and IgG (1.6%, 4/246), IgM (1.6%, 4/246), and arboviral RNA (1.6%, 4/246). Most arboviral diagnostic assays across the studies were serological such as ELISA (50.8%, 125/246), hemagglutination inhibition (HI; 11.4%, 28/246), plaque reduction neutralization test (PRNT; 6.9%, 17/246), and indirect immunofluorescence assay (IIFA; 1.2%, 3/246) while some used molecular tests including RT-PCR (2.4%, 6/246) and sequencing (5.7%, 14/246). A few studies combined both methods, such as ELISA and PRNT (4.5%, 11/246), ELISA, PRNT, and IIFA (0.8%, 2/246), RT-PCR and sequencing (0.4%, 1/246), ELISA and RT-PCR (9.8%, 24/246), and ELISA, RT-PCR, and sequencing (4.9%, 12/246). Among these, 22.8% (56/246) carried out further confirmatory testing: PRNT (42/246; 17.1%), virus neutralization test (VNT; 10/246; 4.1%), FRNT (3/246; 1.2%) and ELISA (1/246; 0.4%) (S6 File).

The studies included in our analysis were undertaken between 1966 and 2021, with the earliest eligible study published in 1970, followed by studies in 1982, 1983, and 1992, totalling to 28 studies. These studies focused on RVFV, CHIKV, CCHFV, SINV, BUNV, ZIKV, YFV, BANV and WNV. Post-2000, the next eligible study was published in 2002 (n=1) and then 2007 (n=11), all focusing on RVFV. There was an increase in published studies from 2007 onwards, peaking in 2010 (n=28), 2015 (n=45) and 2020 (n=37), which coincided with RVFV and DENV outbreaks (Fig. 3). Overall, RVFV was the most consistently studied arbovirus during this entire period, with publications in all identified years except 1970 and 2012. Other arboviruses most frequently studied were CHIKV, DENV, WNV, and YFV (S6 File).

Fig. 3 Number of publications reporting seroprevalence estimates in humans, livestock and/ or wildlife, for each arbovirus by publication year.

Reported IgG prevalence of arboviruses in Kenya RVFV

We calculated a pooled IgG seroprevalence of 7% (95% CI: 4 - 11%; I2: 98%, number of studies: 33) and a prediction interval of 0- 62%, reflecting substantial heterogeneity among the studies in humans. Prevalence ranged from zero in Uasin Gishu (Rift Valley) in 1996 and Kilifi (Coast) in 2004 to a 40% in Nakuru (Rift Valley) in 1989 (Fig. 4A). In livestock, twenty-seven studies reported a pooled prevalence of 10% (95% CI: 8 - 13%; I²: 90%) (Fig. 4B). The prediction interval ranged from 3% to 30%, with the highest prevalence observed in Garissa (North Eastern) in 2015 at 30% and the lowest in Samburu (Rift Valley) and Meru (Eastern), both at 2% in 2006. We observed an IgG seroprevalence of 16% (95% CI: 11 - 24%; I2: 70%, n=15) in wildlife, with a prevalence range from 5% in Taita Taveta and Tana River (both in Coast) in 2007 and 2008, respectively, to 57% in Garissa (North Eastern) in 2007, and a prediction interval of 4% to 51% (Fig. 4C). The most frequently sampled species were buffaloes, warthogs, oryx, waterbuck and impala.

Fig. 4 2Forest plots showing meta-analysis of prevalence for Rift Valley fever virus.

A: humans; B: livestock; and C: wildlife. The first column lists the author and year of study, followed by the area (county/region) in Kenya. Error bars represent the pooled proportions/prevalence of IgG antibodies with their 95% CIs on the log scale for each study. Diamonds indicate the combined point estimate. I² statistics, τ², and Q-test p-values are reported.

Aedes-borne viruses

Of 21 studies focusing on humans, the pooled IgG seroprevalence for DENV was 6% (95% CI: 3–11%; I² = 98%), with a prevalence range from zero in Busia (Western) in 2004 to 67% in Kwale (Coast) in 2000 and 60% in Coastal counties in 2007, and a prediction interval of zero to 67% (Fig. 5A). In wildlife, specifically Papio (baboon) species, a pooled prevalence of 27% (95% CI: 12-49; I2 = 81%) was estimated from two studies, with a prediction interval of 8-61%, the highest prevalence being in Kwale (Coast) at 47% and the lowest in Kakamega (Western) at 15%, both reported in 2014.

Fig. 5. Forest plots showing meta-analysis of prevalence for Aedes-borne viruses. A: Dengue virus; B: Chikungunya virus; and C: Yellow fever virus.

The first column lists the author and year of study, followed by the area (county/region) in Kenya. Error bars represent the pooled proportions/prevalence of IgG antibodies with their 95% CIs on the log scale for each study. Diamonds indicate the combined point estimate. I² statistics, τ², and Q-test p-values are reported.

We reviewed 15 studies reporting CHIKV IgG seroprevalence in humans, showing a pooled prevalence of 10% (95% CI: 4-24%; I² = 15), and a prediction interval of 4-24%. Prevalence ranged from 72% in Lamu (Coast) in 2004 and 67% in Busia (Western) in 2010, to a low of 1% in Nairobi (2008), Central (2007), and Kwale (Coast) in 2009 (Fig. 5B). There was an overall IgG prevalence of 5% (95% CI: 2-11%; I2= 97%, n = 9) for YFV in human populations. The prediction interval was 4-24%, with a prevalence range from a high of 42% in Kwale (Coast) in 2000 to a low of 1% in Kilifi (Coast) and Samburu (Rift Valley), both reported in 2004 (Fig. 5C). The pooled prevalence of IgG ZIKV in humans, from four studies was 2% (95% CI: 1-3%; I2=0%; prediction interval: 0-5%). Reported prevalences ranged from 3% in Kisumu (Nyanza) in 2011 to 1% in Nairobi and Kisumu (Nyanza) in 2009.

Other mosquito-borne viruses

Pooling data from seventeen studies on WNV IgG, we report a pooled prevalence rate of 9% (95% CI: 5-14%; I²=93%), with a prediction interval of 1-51%. The highest prevalence rates were in Tana River in 2009 (34%) and Kwale in 2000 (29%), both in Coast and the lowest in Samburu (Rift Valley) (1%) and Kilifi (Coast) (2%), both reported in 2020. For ONNV, an overall prevalence of 3% (95% CI: 1 - 9%; I2= 76%; n=7) was observed, with a prediction interval of 0- 40%, the highest prevalence being in Lamu (Coast) at 20% in 2008 and the lowest in Nairobi at 1% in 2008. From the only two studies in Rift Valley region in 2022 reporting IgG Ngari in livestock, a pooled prevalence of 38% (95% CI: 31- 46%) with a moderate heterogeneity (I2= 30%) was observed. The prediction interval was 31-46%, with individual prevalence rates of 31% in Kajiado and 24% in Baringo.

Tick-borne viruses

An overall human IgG TBEV prevalence of 7% (95% CI: 5 - 10%; I2=79%) was estimated from ten studies, with a prediction interval of 2-20%, indicating moderate heterogeneity. Prevalence rates ranged from 16% in Kwale (Coast) and 11% in Baringo (Rift Valley) counties in 2000 and 2020, respectively, to 3% in Nandi (Rift Valley) in 2000. For CCHFV, pooled estimates of IgG seroprevalence in humans were 15% (95% CI: 6–33%; I2=97%; n=5), with a prediction interval of zero to 90%. The highest prevalence was reported in Baringo (Rift Valley) in 2009 at 35%, while the lowest was 3% in a nationwide study in 2020. In livestock and wildlife, we report pooled CCHFV prevalence rates of 28% (95% CI: 21–36%; I2=0%; n=1) in Laikipia and Narok counties in Rift Valley, and 75% (95% CI: 69–81%; I2=0%; n=1) in Meru (Eastern) and Laikipia, Narok, Nakuru counties in Rift Valley, all reported in 2007.

Discussion

Our systematic review and meta-analysis, provide insights into the historical occurrence of 14 arboviruses in humans and animals. We focus on RVFV, DENV, CHIKV, YFV, and WNV due to their substantial prevalence and prioritization in key global initiatives like the WHO Blueprint for Prioritized Diseases.

Our findings indicate widespread RVFV seropositivity across humans, livestock and wildlife that is potentially associated with presence of competent vectors, including Aedes, Culex, Mansonia, and Anopheles spp. (10,30), alongside livestock movements related to intensive pastoralism, commercial and sociocultural practices (31–34). The higher seroprevalences in livestock and wildlife than humans are as expected due to more frequent livestock-vector-wildlife transmission, with less common spillover to humans, but still of concern (35). A One Health approach remains vital for monitoring these dynamics and mitigating accordingly. We note that the majority of studies have been concentrated in North Eastern (Garissa, Wajir), Coast (Tana River, Kilifi, Kwale, Taita Taveta), and Rift Valley (Nakuru, Baringo). This focus likely reflects targeted research in “at-risk” areas rather than limited risk elsewhere, thus a need to expand surveillance to under-studied areas to fully capture the national risk (36) For DENV and CHIKV in humans, we report overlapping geographic distributions in Nairobi, Nyanza, Western, and coastal counties (10,30), and indicating risks of cocirculation/ coinfection, particularly in areas with abundant Aedes aegypti mosquitoes. High frequency of outdoor livelihood activities, including pastoralism, farming, and fishing, across much of the country could further increase exposure risk to the day-feeding vector, supporting our findings (37,38). Wildlife may play an important role in DENV transmission in forested areas such as Kwale and Kakamega, either through spillback from humans to nearby Papio species (16,38–40) or via enzootic transmission driven by sylvatic Aedes aegypti formosus (41–43). YFV’s relatively low seroprevalence herein was unexpected, especially given Kenya’s designation by WHO as a high-risk country and routine mass vaccination campaigns albeit only in high-risk counties (44,45). With Kenya’s human YFV vaccination coverage estimated at just 7%, far below WHO-recommended 80% for herd immunity (10,45,46), undetected YFV circulation in susceptible populations alongside competent Aedes spp. (10,30) may explain our findings. However, since the most recent data in our study is from 2017, and dynamics may have shifted, especially after the 2022 outbreak, reassessing YFV prevalence is key in light of current trends. Finally, with no documented outbreaks, WNV substantial seroprevalence in humans suggests sporadic transmission likely linked to migratory birds at convergence zones or local mosquito vectors, including Culex, Mansonia and Aedes spp (10,30,47,48).

Our findings illustrate a persistent, widespread risk of arboviral transmission in Kenya, one that we expect to escalate due to evolving environmental and socioeconomic conditions, including climate change, globalization, urbanization, and rapid population growth (7,49–52). With respect to climate change, heavy rainfall and flooding events influence RVFV (53–57), warmer temperatures and altered precipitation patterns for Ae. aegypti-mediated DENV, CHIKV, and YFV (58–62), and prolonged dry spans and droughts necessitating water storage in containers for DENV and CHIKV (62–64). As climate change intensifies these weather patterns, permissive vectors may expand their geographical range and transmission seasons, potentially exacerbating arboviral threats (49,65). Under the latest IPCC projections, Kenya and much of East Africa is expected to experience mean annual temperature increases of up to 2.1°C (57) with intensified heavy rainfall events (57,66–69) and sustained or reduced drought frequency (70–73). Consequently, extensive outbreaks in established hotspots could worsen, and previously unaffected or less affected regions in Kenya may emerge as new hotspots. Mordecai et al. suggest that climate-driven shifts could create complex changes in the incidence of arboviruses and malaria, with warmer temperatures potentially favoring one over the other depending on the region (51). In Kenya, this could worsen the dual burden of arboviruses and malaria, additionally straining the health system and complicating public health efforts. Rapid, often unplanned urbanization, characterized by mushrooming slums, overcrowding and poor sanitation, provides conducive breeding conditions for Ae. aegypti and Culex pipiens, which could facilitate the rapid spread of DENV, CHIKV, ZIKV and WNV (7,74–76). This is reflected in our findings of considerable prevalence of Aedes-borne viruses in urban centers like Nairobi, Mombasa, Kisumu, Busia, and Malindi. This transmission risk may be further compounded by the urban heat island effect in Nairobi, and other cities that could enhance mosquito survival and reproduction, while the urban sprawl could potentially hamper vector control measures like larval source management (77–79). As Kenya’s cities and towns continue to expand and with more than 50% of Kenyans projected to live in urban centres by 2030 (80,81), the threat of urban arbovirus outbreaks in the country is significant. Further, Ae. albopictus, a highly adaptable species, was recorded in Kenya’s neighbors nearly a decade ago (7,49–52) and could already be in Kenya undetected (82), raising concerns about its potential to facilitate the spread of arboviruses in both urban and rural settings, further complicating control efforts.

Beyond expansion of urban and peri-urban centres, deforestation, intensive pastoralism, land-use change and encroachment of human settlements into previously uninhabited areas could also increase arbovirus risk by disrupting natural ecosystems and increasing human-sylvatic vector interactions (83,84). Additionally, globalization—through increased international travel, tourism and trade—compounds these risks by facilitating the movement of infected people and livestock across borders, potentially introducing new strains of arboviruses into Kenya and triggering outbreaks in previously unaffected regions (85–88). Our findings support this, with substantial representation of Aedes-borne viruses in the trade and tourism-intensive coastal counties of Mombasa, Kwale, Kilifi, and Lamu.This is particularly concerning for viruses like DENV and CHIKV, which have a propensity for rapid spread in new environments (89–91), and is especially relevant for coastal counties like Mombasa, where high volumes of international goods importation and tourism could also introduce invasive mosquito species like Ae. albopictus.

Mitigating these projected surging arboviral threats in Kenya requires aligning national efforts with global frameworks like the GAI, Global Vector Control Response (GVCR), and WHO Regional Framework for monitoring invasive species (92–94)Kenya’s surveillance infrastructure, particularly the Integrated Disease Surveillance and Response (IDSR) system, has traditionally relied on passive surveillance methods with marked successes in detecting outbreaks like cholera and malaria (95,96). It is, however, often limited by underreporting and delays, limiting its capacity to fully monitor arboviral activity across the country (97) Further, deficiencies in diagnostic capacities, data integration across human, animal, vector and environmental health sectors, and insufficient personnel training have emerged as limiting factors in Kenya’s capacity for arboviral surveillance and control (98). To bridge these gaps, Kenya needs to incorporate more active surveillance methods within a One Health framework including expanding entomological surveillance, streamlining reporting mechanisms, and leveraging geographic information systems and remote sensing technologies that could improve Kenya’s ability to monitor vector populations and predict outbreak hotspots before they escalate (92,99) More focus on arbovirus co-infections and their clinical outcomes is needed in Kenya, as most included studies examined single viruses at a time, despite many vectors like Aedes and Culex spp. often harbouring multiple viruses simultaneously (100). Future research should also prioritize longitudinal studies across diverse ecological zones to comprehensively assess arbovirus circulation and transmission dynamics across the country. Further, diagnostic challenges such as overlapping clinical symptoms, cross-reactivity, and persistence of antibodies among many arboviruses limit the ability of laboratories in the region to generate accurate exposure data. Incorporating more specific case definitions, along with expanding the diagnostic capabilities — accurate point-of-care diagnostics especially in remote, resource-limited settings — is key for timely outbreak detection and management (51,101).

With no vaccines available for most arboviruses, integrated vector management (IVM) remains the most viable approach for outbreak prevention and response (89). In Kenya, existing vector control efforts, including larval source management (LSM), insecticide-treated nets (ITNs), and indoor residual spraying (IRS), were primarily developed to combat malaria and have successfully reduced its burden (102,103). Yet, this focus has left arboviruses largely neglected. To correct this imbalance while maximizing resource efficiency, Kenya can leverage these existing infrastructure and resources to control arboviruses, adopting them to specific vector needs (89). For example, while LSM and larvicides may apply across Anopheles (malaria) and some Aedes species, ITNs may be less effective due to vector biology and behavior differences (89,104)Further, given Kenya’s dual burden, these arbovirus interventions should complement and not detract from malaria control achievable, for instance, by training malaria control experts in arbovirus management and securing funding agreements to prevent resource diversion from the already underfunded malaria programs (89,105) Tailoring these interventions to local contexts and scaling up through community-based approaches, including health education and promotion, environmental cleanup, and leveraging the role of gender dynamics in household-level vector control, is also critical for ensuring their sustainability and success (51,93,104,106) Additionally, strengthening these strategies through multisectoral collaboration across agriculture, environment, urban planning, education and public health, would foster a more holistic and coordinated approach to arboviral threats nationwide (106).

To reinforce Kenya’s response to arboviral outbreaks, developing and refining targeted contingency plans is essential. Kenya has made some progress in this regard with the RVFV contingency plan, which has been periodically updated to focus on high-risk areas such as Isiolo and Wajir (107). These plans should be further adapted by pre-positioning resources in these regions, training healthcare workers in rapid response protocols, and ensuring the IDSR system is fully equipped to handle the nuances of arboviral outbreaks (108,109). Kenya can also capitalize our findings to contribute to a national dedicated arbovirus dashboard— per GAI’s priority actions—as a comprehensive tool for real-time monitoring, optimal resource allocation and improved coordination during outbreaks(7,9)Further, multicountry collaborations through regional networks like the East African Community and African Union, alongside global partners through the GAI, could provide Kenya with additional resources, expertise and data to strengthen its capacity to manage local and cross-border threats, while also supporting continent-level early warning systems (7,93).

Our findings may however be limited by substantial heterogeneity, as sources of heterogeneity, such as varying methodologies, population characteristics, and confirmation cut-offs were not reported in many studies and could not be assessed. Additionally, our county-level data, based on sampled areas, may not fully represent local ecological and climatic diversity, necessitating caution in extrapolating findings to entire counties. Ascertainment bias may also be present, as included studies predominantly focused in identified “hotspot” areas, potentially overrepresenting them. Finally, reliance on ELISA without PRNT or RT-PCR confirmation across most studies raises concerns on results accuracy and reliability. Nonetheless, our study reveals an extensive longstanding history of arboviral circulation in Kenya, with future risks projected to increase due to ecological, environmental, and socioeconomic factors. For effective mitigation, strengthening surveillance, enhancing integrated vector management, and improving outbreak response and prevention efforts are key. By addressing these key areas through targeted interventions and regional cooperation, Kenya can better position itself to effectively manage the growing risk of arboviral diseases.

Data Availability

All relevant data has been included in the manuscript and supplementary material.

Contributors

L.J.K. conceived the study, conducted the systematic search, and was the first reviewer for the entire study. R.N., E.K., H.A. and J.L. contributed to screening, data extraction and quality appraisal. L.J.K. and J.L. conducted the statistical analysis, and L.J.K. wrote the first draft of the manuscript with input from J.L. and H.A., B.B., J.A. and D.M. reviewed the manuscript and gave input on the statistical analysis and interpretation of results. All authors contributed to drafting and revising the manuscript.

Declaration of interests

All authors declare no competing interests.

Data sharing

All relevant data has been included in the manuscript and supplementary material.

Supplementary materials

Acknowledgements

The authors express their gratitude for the funding by DTRA HDTRA11910031. D.M.M was supported by the ILRI/BMZ One Health Research, Education, Outreach and Awareness Centre (OHRECA) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  1. 1.↵
    WHO. Vector-borne diseases [Internet]. 2020 [cited 2023 Jul 4]. Available from: https://www.who.int/news-room/fact-sheets/detail/vector-borne-diseases
  2. 2.↵
    Agboli E, Tomazatos A, Maiga-Ascofaré O, May J, Lühken R, Schmidt-Chanasit J, et al. Arbovirus Epidemiology: The Mystery of Unnoticed Epidemics in Ghana, West Africa. Vol. 10, Microorganisms. MDPI; 2022.
  3. 3.↵
    Marchi S, Trombetta CM, Montomoli E, Marchi S, Trombetta CM, Montomoli E. Emerging and Re-emerging Arboviral Diseases as a Global Health Problem. Public Health - Emerging and Re-emerging Issues [Internet]. 2018 Nov 5 [cited 2023 Jul 22]; Available from: https://www.intechopen.com/chapters/61770
  4. 4.↵
    Anez G, Chancey C, Grinev A, Rios M. Dengue virus and other arboviruses: a global view of risks. ISBT Sci Ser [Internet]. 2012 Jul 1 [cited 2023 Jul 30];7(1):274–82. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/j.1751-2824.2012.01602.x
    OpenUrl
  5. 5.↵
    Higuera A, Ramírez JD. Molecular epidemiology of dengue, yellow fever, Zika and Chikungunya arboviruses: An update. Acta Trop. 2019 Feb 1;190:99–111.
    OpenUrlPubMed
  6. 6.
    Tajudeen YA, Oladipo HJ, Oladunjoye IO, Yusuf RO, Sodiq H, Omotosho AO, et al. Emerging Arboviruses of Public Health Concern in Africa: Priorities for Future Research and Control Strategies. Challenges [Internet]. 2022 Nov 18;13(2):60. Available from: https://www.mdpi.com/2078-1547/13/2/60
    OpenUrl
  7. 7.↵
    Longbottom J, Walekhwa AW, Mwingira V, Kijanga O, Mramba F, Lord JS. Aedes albopictus invasion across Africa: the time is now for cross-country collaboration and control. Lancet Glob Health [Internet]. 2023 Apr 1 [cited 2024 Aug 27];11(4):e623–8. Available from: http://www.thelancet.com/article/S2214109X23000463/fulltext
    OpenUrl
  8. 8.↵
    Wallau GL, Abanda NN, Abbud A, Abdella S, Abera A, Ahuka-Mundeke S, et al. Arbovirus researchers unite: expanding genomic surveillance for an urgent global need. Lancet Glob Health [Internet]. 2023 Oct 1 [cited 2024 May 6];11(10):e1501–2. Available from: http://www.thelancet.com/article/S2214109X2300325X/fulltext
    OpenUrl
  9. 9.↵
    WHO. Global Arbovirus Initiative: preparing for the next pandemic by tackling mosquito-borne viruses with epidemic and pandemic potential [Internet]. Geneva; 2024 [cited 2024 May 6]. Available from: https://www.who.int/initiatives/global-arbovirus-initiative
  10. 10.↵
    Karungu S, Atoni E, Ogalo J, Mwaliko C, Agwanda B, Yuan Z, et al. Mosquitoes of Etiological Concern in Kenya and Possible Control Strategies. Insects 2019, Vol 10, Page 173 [Internet]. 2019 Jun 16 [cited 2023 Jul 28];10(6):173. Available from: https://www.mdpi.com/2075-4450/10/6/173/htm
    OpenUrl
  11. 11.↵
    LaBeaud AD, Sutherland LJ, Muiruri S, Muchiri EM, Gray LR, Zimmerman PA, et al. Arbovirus Prevalence in Mosquitoes, Kenya. Emerg Infect Dis [Internet]. 2011 Feb [cited 2023 Aug 12];17(2):233. Available from: /pmc/articles/PMC3204744/
    OpenUrl
  12. 12.
    Mease LE, Coldren RL, Musila LA, Prosser T, Ogolla F, Ofula VO, et al. Seroprevalence and distribution of arboviral infections among rural Kenyan adults: A cross-sectional study [Internet]. Vol. 8, Virology Journal. 2011. Available from: http://www.virologyj.com/content/8/1/371
  13. 13.↵
    Kimata Y, Borus P, Nzunza R, Ofula V, Chepkorir E, Waihenya R, et al. Serological Evidence of Chikungunya Virus Infection among Suspected Measles Cases in Selected Regions of Kenya: 2008-2014. Vector-Borne and Zoonotic Diseases. 2020 Dec 1;20(12):903–9.
    OpenUrl
  14. 14.↵
    Atoni E, Waruhiu C, Nganga S, Xia H, Yuan Z. Arboviruses of human health significance in Kenya. Afr J Health Sci. 2018;31(1):121–41.
    OpenUrl
  15. 15.↵
    Philbert A, Majalija S, Lyantagaye SL, Anitha P. Arbovirus Vectors of Epidemiological Concern in East Africa: A systematic review of entomological studies (1940-2020). Afr J Health Sci [Internet]. 2022 Dec 6 [cited 2023 Jul 28];35(4):496–520. Available from: https://www.ajol.info/index.php/ajhs/article/view/237737
    OpenUrl
  16. 16.↵
    Vu DM, Mutai N, Heath CJ, Vulule JM, Mutuku FM, Ndenga BA, et al. Unrecognized Dengue Virus Infections in Children, Western Kenya, 2014–2015. Emerg Infect Dis [Internet]. 2017 Nov 1 [cited 2024 Apr 27];23(11):1915. Available from: /pmc/articles/PMC5652413/
    OpenUrl
  17. 17.↵
    Chiuya T, Villinger J, Falzon LC, Alumasa L, Amanya F, Bastos ADS, et al. Molecular screening reveals non-uniform malaria transmission in western Kenya and absence of Rickettsia africae and selected arboviruses in hospital patients. Malar J [Internet]. 2022 Dec 1 [cited 2024 Sep 16];21(1):268. Available from: /pmc/articles/PMC9482282/
    OpenUrl
  18. 18.↵
    Bosire C, Mutuku F, Ndenga B, Nzaro M, Mwendwa K, Labeaud AD. A narrative review of dengue fever infection and epidemic activity in Kenya (2010 to 2020). PAMJ-OH 2023; 12:10 [Internet]. 2023 Oct 16 [cited 2024 Sep 16];12(10). Available from: https://www.one-health.panafrican-med-journal.com/content/article/12/10/full
  19. 19.↵
    LaBeaud AD, Sutherland LJ, Muiruri S, Muchiri EM, Gray LR, Zimmerman PA, et al. Arbovirus Prevalence in Mosquitoes, Kenya. Emerg Infect Dis [Internet]. 2011 Feb [cited 2024 Sep 16];17(2):233. Available from: /pmc/articles/PMC3204744/
    OpenUrl
  20. 20.↵
    Moher D, Liberati A, Tetzlaff J, Altman DG, Altman D, Antes G, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Vol. 6, PLoS Medicine. 2009.
  21. 21.↵
    Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016 Dec 5;5(1).
  22. 22.↵
    Piper C. System for the unified management, assessment, and review of information (SUMARI). Vol. 107, Journal of the Medical Library Association. Medical Library Association; 2019. p. 634–6.
    OpenUrl
  23. 23.↵
    Munn Z, MClinSc SM, Lisy K, Riitano D, Tufanaru C. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Healthc [Internet]. 2015 Sep 1 [cited 2024 Apr 27];13(3):147–53. Available from: https://pubmed.ncbi.nlm.nih.gov/26317388/
    OpenUrl
  24. 24.↵
    Morissette K, Tricco AC, Horsley T, Chen MH, Moher D. Blinded versus unblinded assessments of risk of bias in studies included in a systematic review. Cochrane Database Syst Rev [Internet]. 2011 Sep 7 [cited 2023 Aug 2];2011(9). Available from: /pmc/articles/PMC7433288/
  25. 25.
    Sargeant JM, O’Connor AM. Scoping Reviews, Systematic Reviews, and Meta-Analysis: Applications in Veterinary Medicine. Front Vet Sci. 2020 Jan 28;7:502756.
  26. 26.↵
    Gebremariam TT, Schallig HDFH, Mekonnen Z, Hailu A, Danquah JB. Concurrent malaria and dengue fever in (sub-Saharan) Africa: a systematic review and meta-analysis. medRxiv [Internet]. 2022 Jun 6 [cited 2024 Apr 27];2022.05.24.22275526. Available from: https://www.medrxiv.org/content/10.1101/2022.05.24.22275526v3
  27. 27.↵
    Borenstein M, Higgins JPT, Hedges L V., Rothstein HR. Basics of meta-analysis: I2 is not an absolute measure of heterogeneity. Res Synth Methods [Internet]. 2017 Mar 1 [cited 2023 Aug 2];8(1):5–18. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/jrsm.1230
    OpenUrl
  28. 28.↵
    Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Community Health [Internet]. 2013 Nov 1 [cited 2023 Aug 2];67(11):974–8. Available from: https://jech.bmj.com/content/67/11/974
    OpenUrl
  29. 29.
    Salgado BB, de Jesus Maués FC, Pereira RL, Chiang JO, de Oliveira Freitas MN, Ferreira MS, et al. Prevalence of arbovirus antibodies in young healthy adult population in Brazil. Parasit Vectors [Internet]. 2021 Dec 1 [cited 2023 Aug 22];14(1):1–11. Available from: https://parasitesandvectors.biomedcentral.com/articles/10.1186/s13071-021-04901-4
    OpenUrl
  30. 30.↵
    Lutomiah J, Bast J, Clark J, Richardson J, Yalwala S, Oullo D, et al. Abundance, diversity, and distribution of mosquito vectors in selected ecological regions of Kenya: public health implications. Journal of Vector Ecology [Internet]. 2013 Jun 1 [cited 2024 Apr 16];38(1):134–42. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/j.1948-7134.2013.12019.x
    OpenUrl
  31. 31.↵
    Anyangu AS, Gould LH, Sharif SK, Nguku PM, Omolo JO, Mutonga D, et al. Risk factors for severe Rift Valley fever infection in Kenya, 2007. Am J Trop Med Hyg [Internet]. 2010 Aug [cited 2024 Apr 27];83(2 Suppl):14–21. Available from: https://pubmed.ncbi.nlm.nih.gov/20682901/
    OpenUrl
  32. 32.
    Muga GO, Onyango-Ouma W, Sang R, Affognon H. Sociocultural and Economic Dimensions of Rift Valley Fever. Am J Trop Med Hyg [Internet]. 2015 Apr 1 [cited 2024 May 5];92(4):730–8. Available from: https://www.ajtmh.org/view/journals/tpmd/92/4/article-p730.xml
    OpenUrl
  33. 33.
    Amwata DA, Nyariki DM, Musimba NRK. Factors Influencing Pastoral and Agropastoral Household Vulnerability to Food Insecurity in the Drylands of Kenya: A Case Study of Kajiado and Makueni Counties. J Int Dev [Internet]. 2016 Jul 1 [cited 2024 May 3];28(5):771–87. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/jid.3123
    OpenUrl
  34. 34.↵
    Kariuki RW, Western D, Willcock S, Marchant R. Assessing Interactions between Agriculture, Livestock Grazing and Wildlife Conservation Land Uses: A Historical Example from East Africa. Land 2021, Vol 10, Page 46 [Internet]. 2021 Jan 6 [cited 2024 May 3];10(1):46. Available from: https://www.mdpi.com/2073-445X/10/1/46/htm
    OpenUrl
  35. 35.↵
    Ebogo-Belobo JT, Kenmoe S, Abanda NN, Bowo-Ngandji A, Mbaga DS, Magoudjou-Pekam JN, et al. Contemporary epidemiological data of Rift Valley fever virus in humans, mosquitoes and other animal species in Africa: A systematic review and meta-analysis. Vet Med Sci [Internet]. 2023 [cited 2023 Aug 28]; Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/vms3.1238
  36. 36.↵
    Salje H, Paul KK, Paul R, Rodriguez-Barraquer I, Rahman Z, Alam MS, et al. Nationally-representative serostudy of dengue in Bangladesh allows generalizable disease burden estimates. Elife [Internet]. 2019 [cited 2024 Sep 24];8. Available from: https://pubmed.ncbi.nlm.nih.gov/30958263/
  37. 37.↵
    Ferede G, Tiruneh M, Abate E, Wondimeneh Y, Damtie D, Gadisa E, et al. A serologic study of dengue in northwest Ethiopia: Suggesting preventive and control measures. PLoS Negl Trop Dis [Internet]. 2018 May 31 [cited 2024 May 5];12(5). Available from: /pmc/articles/PMC5978788/
  38. 38.↵
    Ochieng C, Ahenda P, Vittor AY, Nyoka R, Gikunju S, Wachira C, et al. Seroprevalence of Infections with Dengue, Rift Valley Fever and Chikungunya Viruses in Kenya, 2007. PLoS One [Internet]. 2015 Jul 15 [cited 2024 May 5];10(7):132645. Available from: /pmc/articles/PMC4503415/
    OpenUrl
  39. 39.
    Chowdhury S, Brown J, Swedell L. Anthropogenic effects on the physiology and behaviour of chacma baboons in the Cape Peninsula of South Africa. Conserv Physiol [Internet]. 2020 [cited 2024 May 3];8(1). Available from: /pmc/articles/PMC7428446/
  40. 40.↵
    Kifle Z. Human-olive baboon (Papio anubis) conflict in the human-modified landscape, Wollo, Ethiopia. Glob Ecol Conserv. 2021 Nov 1;31:e01820.
    OpenUrl
  41. 41.↵
    Yalwala S, Clark J, Oullo D, Ngonga D, Abuom D, Wanja E, et al. Comparative efficacy of existing surveillance tools for Aedes aegypti in Western Kenya. Journal of Vector Ecology [Internet]. 2015 Dec 1 [cited 2024 Apr 15];40(2):301–7. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/jvec.12168
    OpenUrl
  42. 42.
    McBride CS, Baier F, Omondi AB, Spitzer SA, Lutomiah J, Sang R, et al. Evolution of mosquito preference for humans linked to an odorant receptor. Nature 2014 515:7526 [Internet]. 2014 Nov 12 [cited 2024 Apr 18];515(7526):222–7. Available from: https://www.nature.com/articles/nature13964
    OpenUrl
  43. 43.↵
    Trpis M, Hausermann W. Demonstration of differential domesticity of Aedes aegypti (L.) (Diptera, Culicidae) in Africa by mark-release-recapture. Bull Entomol Res [Internet]. 1975 [cited 2024 Apr 25];65(2):199–208. Available from: https://www.cambridge.org/core/journals/bulletin-of-entomological-research/article/abs/demonstration-of-differential-domesticity-of-aedes-aegypti-l-diptera-culicidae-in-africa-by-markreleaserecapture/BE254383B7D369295031265FE56D4464
    OpenUrl
  44. 44.↵
    Yellow Fever - Kenya [Internet]. [cited 2024 Sep 18]. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON361
  45. 45.↵
    WHO. Yellow Fever – Kenya [Internet]. 2016 [cited 2023 Jul 22]. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/6-april-2016-yellow-fever-kenya-en
  46. 46.↵
    Lutomiah J, Bast J, Clark J, Richardson J, Yalwala S, Oullo D, et al. Abundance, diversity, and distribution of mosquito vectors in selected ecological regions of Kenya: public health implications. Journal of Vector Ecology [Internet]. 2013 Jun 1 [cited 2024 Apr 15];38(1):134–42. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/j.1948-7134.2013.12019.x
    OpenUrl
  47. 47.↵
    Nyamwaya D, Wang’ondu V, Amimo J, Michuki G, Ogugo M, Ontiri E, et al. Detection of West Nile virus in wild birds in Tana River and Garissa Counties, Kenya. BMC Infect Dis. 2016 Nov 23;16(1).
  48. 48.↵
    Ochieng C, Lutomiah J, Makio A, Koka H, Chepkorir E, Yalwala S, et al. Mosquito-borne arbovirus surveillance at selected sites in diverse ecological zones of Kenya; 2007–2012. Virol J. 2013;10:1–10.
    OpenUrlCrossRefPubMed
  49. 49.↵
    Liang G, Gao X, Gould EA. Factors responsible for the emergence of arboviruses; strategies, challenges and limitations for their control. Emerg Microbes Infect [Internet]. 2015 Mar 25 [cited 2024 Aug 28];4(3). Available from: https://www.tandfonline.com/doi/abs/10.1038/emi.2015.18
  50. 50.
    Sukhralia S, Verma M, Gopirajan S, Dhanaraj PS, Lal R, Mehla N, et al. From dengue to Zika: the wide spread of mosquito-borne arboviruses. European Journal of Clinical Microbiology and Infectious Diseases [Internet]. 2019 Jan 22 [cited 2024 Aug 28];38(1):3–14. Available from: https://link.springer.com/article/10.1007/s10096-018-3375-7
    OpenUrl
  51. 51.↵
    Mordecai EA, Ryan SJ, Caldwell JM, Shah MM, LaBeaud AD. Climate change could shift disease burden from malaria to arboviruses in Africa. Lancet Planet Health [Internet]. 2020 Sep 1 [cited 2023 Aug 10];4(9):e416–23. Available from: http://www.thelancet.com/article/S2542519620301789/fulltext
    OpenUrl
  52. 52.↵
    Lim AY, Jafari Y, Caldwell JM, Clapham HE, Gaythorpe KAM, Hussain-Alkhateeb L, et al. A systematic review of the data, methods and environmental covariates used to map Aedes-borne arbovirus transmission risk. BMC Infect Dis [Internet]. 2023 Dec 1 [cited 2024 Aug 27];23(1):1–18. Available from: https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-023-08717-8
    OpenUrlCrossRef
  53. 53.↵
    Oyas H, Holmstrom L, Kemunto NP, Muturi M, Mwatondo A, Osoro E, et al. Enhanced surveillance for Rift Valley Fever in livestock during El Niño rains and threat of RVF outbreak, Kenya, 2015-2016. PLoS Negl Trop Dis [Internet]. 2018 Apr 26 [cited 2023 Aug 9];12(4). Available from: /pmc/articles/PMC5919633/
  54. 54.
    Munyua P, Murithi RM, Wainwright S, Githinji J, Hightower A, Mutonga D, et al. Rift Valley fever outbreak in livestock in Kenya, 2006-2007. Am J Trop Med Hyg [Internet]. 2010 Aug [cited 2023 Aug 12];83(2 Suppl):58–64. Available from: https://pubmed.ncbi.nlm.nih.gov/20682907/
    OpenUrl
  55. 55.
    Hassan A, Muturi M, Mwatondo A, Omolo J, Bett B, Gikundi S, et al. Epidemiological Investigation of a Rift Valley Fever Outbreak in Humans and Livestock in Kenya, 2018. Am J Trop Med Hyg [Internet]. 2020 Oct 1 [cited 2024 Apr 27];103(4):1649–55. Available from: https://pubmed.ncbi.nlm.nih.gov/32748778/
    OpenUrl
  56. 56.
    Nguku PM, Sharif SK, Mutonga D, Amwayi S, Omolo J, Mohammed O, et al. An investigation of a major outbreak of Rift Valley fever in Kenya: 2006-2007. Am J Trop Med Hyg [Internet]. 2010 Aug [cited 2024 Apr 27];83(2 Suppl):5–13. Available from: https://pubmed.ncbi.nlm.nih.gov/20682900/
    OpenUrl
  57. 57.↵
    Africa. Climate Change 2022 – Impacts, Adaptation and Vulnerability [Internet]. 2023 Jun 22 [cited 2024 Sep 17];1285–456. Available from: https://www.cambridge.org/core/product/identifier/9781009325844%23c9/type/book_part
  58. 58.↵
    Wilder-Smith A, Monath TP. Responding to the threat of urban yellow fever outbreaks. Lancet Infect Dis. 2017 Mar 1;17(3):248–50.
    OpenUrlCrossRefPubMed
  59. 59.
    Sang RC, Dunster LM. The growing threat of arbovirus transmission and outbreaks in Kenya: a review. East Afr Med J [Internet]. 2001 [cited 2023 Aug 10];78(12):655–61. Available from: https://pubmed.ncbi.nlm.nih.gov/12199448/
    OpenUrl
  60. 60.
    Uwishema O, Eneh SC, Chiburoma AG, Fadl Elhassan WA, Abdur-Rahman Adekunle A, Rogose MS, et al. Yellow fever outbreak in Kenya: A review. Annals of Medicine and Surgery [Internet]. 2022 Oct 1 [cited 2023 Aug 22];82:104537. Available from: /pmc/articles/PMC9577449/
    OpenUrl
  61. 61.
    Lutomiah J, Barrera R, Makio A, Mutisya J, Koka H, Owaka S, et al. Dengue Outbreak in Mombasa City, Kenya, 2013–2014: Entomologic Investigations. PLoS Negl Trop Dis [Internet]. 2016 Oct 26 [cited 2023 Jul 30];10(10):e0004981. Available from: https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0004981
    OpenUrl
  62. 62.↵
    Ellis EM, Neatherlin JC, Delorey M, Ochieng M, Mohamed AH, Mogeni DO, et al. A Household Serosurvey to Estimate the Magnitude of a Dengue Outbreak in Mombasa, Kenya, 2013. PLoS Negl Trop Dis. 2015 Apr 29;9(4).
  63. 63.
    Obonyo M, Fidhow A, Ofula V. Investigation of laboratory confirmed Dengue outbreak in North-eastern Kenya, 2011. PLoS One [Internet]. 2018 Jun 1 [cited 2024 Apr 27];13(6):e0198556. Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0198556
    OpenUrl
  64. 64.↵
    Konongoi SL, Nyunja A, Ofula V, Owaka S, Koka H, Koskei E, et al. Human and entomologic investigations of chikungunya outbreak in Mandera, Northeastern Kenya, 2016. PLoS One [Internet]. 2018 Oct 1 [cited 2024 Apr 27];13(10):e0205058. Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0205058
    OpenUrl
  65. 65.↵
    Robert MA, Stewart-Ibarra AM, Estallo EL. Climate change and viral emergence: evidence from Aedes-borne arboviruses. Curr Opin Virol [Internet]. 2020 Feb 1 [cited 2024 Aug 29];40:41. Available from: /pmc/articles/PMC7305058/
    OpenUrl
  66. 66.↵
    Nikulin G, Lennard C, Dosio A, Kjellström E, Chen Y, Hansler A, et al. The effects of 1.5 and 2 degrees of global warming on Africa in the CORDEX ensemble. Environmental Research Letters [Internet]. 2018 May 25 [cited 2024 Sep 17];13(6):065003. Available from: https://iopscience.iop.org/article/10.1088/1748-9326/aab1b1
    OpenUrl
  67. 67.
    Ogega OM, Koske J, Kung’u JB, Scoccimarro E, Endris HS, Mistry MN. Heavy precipitation events over East Africa in a changing climate: results from CORDEX RCMs. Clim Dyn [Internet]. 2020 Aug 1 [cited 2024 Sep 17];55(3–4):993–1009. Available from: https://link-springer-com-443.webvpn.synu.edu.cn/article/10.1007/s00382-020-05309-z
    OpenUrl
  68. 68.
    Finney DL, Marsham JH, Rowell DP, Kendon EJ, Tucker SO, Stratton RA, et al. Effects of Explicit Convection on Future Projections of Mesoscale Circulations, Rainfall, and Rainfall Extremes over Eastern Africa. J Clim [Internet]. 2020 Apr 1 [cited 2024 Sep 17];33(7):2701–18. Available from: https://journals.ametsoc.org/view/journals/clim/33/7/jcli-d-19-0328.1.xml
    OpenUrl
  69. 69.↵
    Li C, Zwiers F, Zhang X, Li G, Sun Y, Wehner M. Changes in Annual Extremes of Daily Temperature and Precipitation in CMIP6 Models. J Clim [Internet]. 2021 May 1 [cited 2024 Sep 17];34(9):3441–60. Available from: https://journals.ametsoc.org/view/journals/clim/34/9/JCLI-D-19-1013.1.xml
    OpenUrl
  70. 70.↵
    Liu W, Sun F, Ho Lim W, Zhang J, Wang H, Shiogama H, et al. Global drought and severe drought-Affected populations in 1.5 and 2 °C warmer worlds. Earth System Dynamics. 2018 Mar 19;9(1):267–83.
    OpenUrl
  71. 71.
    Haile GG, Tang Q, Hosseini-Moghari SM, Liu X, Gebremicael TG, Leng G, et al. Projected Impacts of Climate Change on Drought Patterns Over East Africa. Earths Future [Internet]. 2020 Jul 1 [cited 2024 Sep 17];8(7):e2020EF001502. Available from: https://onlinelibrary.wiley.com/doi/full/10.1029/2020EF001502
    OpenUrl
  72. 72.
    Nguvava M, Abiodun BJ, Otieno F. Projecting drought characteristics over East African basins at specific global warming levels. Atmos Res. 2019 Nov 1;228:41–54.
    OpenUrl
  73. 73.↵
    Spinoni J, Barbosa P, Bucchignani E, Cassano J, Cavazos T, Christensen JH, et al. Future global meteorological drought hot spots: A study based on CORDEX data. J Clim. 2020 May 1;33(9):3635–61.
    OpenUrl
  74. 74.↵
    Kolimenakis A, Heinz S, Wilson ML, Winkler V, Yakob L, Michaelakis A, et al. The role of urbanisation in the spread of Aedes mosquitoes and the diseases they transmit—A systematic review. PLoS Negl Trop Dis [Internet]. 2021 Sep 1 [cited 2024 Aug 27];15(9). Available from: /pmc/articles/PMC8428665/
  75. 75.
    Agha SB, Tchouassi DP. Urbanization of Aedes mosquito populations and evolution of arboviral disease risk in Africa. Curr Opin Insect Sci. 2022 Dec 1;54:100988.
  76. 76.↵
    Giesen C, Herrador Z, Fernandez-Martinez B, Figuerola J, Gangoso L, Vazquez A, et al. A systematic review of environmental factors related to WNV circulation in European and Mediterranean countries. One Health. 2023 Jun 1;16:100478.
  77. 77.↵
    Almeida LS, Cota ALS, Rodrigues DF. Sanitation, Arboviruses, and Environmental Determinants of Disease: impacts on urban health. Cien Saude Colet. 2020;25:3857–68.
    OpenUrlPubMed
  78. 78.
    Ochola EM, Fakharizadehshirazi E, Adimo AO, Mukundi JB, Wesonga JM, Sodoudi S. Inter-local climate zone differentiation of land surface temperatures for Management of Urban Heat in Nairobi City, Kenya. Urban Clim. 2020 Mar 1;31:100540.
  79. 79.↵
    de Azevedo TS, Bourke BP, Piovezan R, Sallum MAM. The influence of urban heat Islands and socioeconomic factors on the spatial distribution of Aedes aegypti larval habitats. Geospat Health. 2018 May 7;13(1):179–87.
    OpenUrl
  80. 80.↵
    Urbanization in Kenya: Building inclusive & sustainable cities [Internet]. [cited 2024 Aug 28]. Available from: https://unhabitat.org/kenya
  81. 81.↵
    Owino EA. Aedes spp mosquitoes and emerging neglected diseases of Kenya. Int J Mosq Res. 2018;5(5):1–11.
    OpenUrl
  82. 82.↵
    Oliveira S, Capinha C, Rocha J. Predicting the time of arrival of the Tiger mosquito (Aedes albopictus) to new countries based on trade patterns of tyres and plants. Journal of Applied Ecology [Internet]. 2023 Nov 1 [cited 2024 Aug 28];60(11):2362–74. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/1365-2664.14503
    OpenUrl
  83. 83.↵
    Eastwood G, Sang RC, Guerbois M, Taracha ELN, Weaver SC. Enzootic circulation of chikungunya virus in East Africa: Serological evidence in non-human Kenyan primates. American Journal of Tropical Medicine and Hygiene. 2017;97(5):1399–404.
    OpenUrlCrossRefPubMed
  84. 84.↵
    Eastwood G, Sang RC, Lutomiah J, Tunge P, Weaver SC. Sylvatic Mosquito Diversity in Kenya—Considering Enzootic Ecology of Arboviruses in an Era of Deforestation. Insects 2020, Vol 11, Page 342 [Internet]. 2020 Jun 3 [cited 2024 Aug 28];11(6):342. Available from: https://www.mdpi.com/2075-4450/11/6/342/htm
    OpenUrl
  85. 85.↵
    Salkeld D, Hopkins S, Hayman D. Emerging infectious diseases and globalization—travel, trade, and invasive species. Emerging Zoonotic and Wildlife Pathogens [Internet]. 2023 Dec 14 [cited 2024 Aug 29];175–98. Available from: https://academic.oup.com/book/55315/chapter/428751306
  86. 86.
    Mayer S V., Tesh RB, Vasilakis N. The emergence of arthropod-borne viral diseases: A global prospective on dengue, chikungunya and zika fevers. Acta Trop [Internet]. 2017 Feb 1 [cited 2023 Jul 30];166:155–63. Available from: https://pubmed.ncbi.nlm.nih.gov/27876643/
    OpenUrl
  87. 87.
    Girard M, Nelson CB, Picot V, Gubler DJ. Arboviruses: A global public health threat. Vaccine [Internet]. 2020 May 5 [cited 2024 Aug 29];38(24):3989. Available from: /pmc/articles/PMC7180381/
    OpenUrl
  88. 88.↵
    Braack L, Gouveia De Almeida AP, Cornel AJ, Swanepoel R, De Jager C. Mosquito-borne arboviruses of African origin: review of key viruses and vectors. Parasites & Vectors 2018 11:1 [Internet]. 2018 Jan 9 [cited 2023 Jul 31];11(1):1–26. Available from: https://parasitesandvectors.biomedcentral.com/articles/10.1186/s13071-017-2559-9
    OpenUrl
  89. 89.↵
    Weetman D, Kamgang B, Badolo A, Moyes CL, Shearer FM, Coulibaly M, et al. Aedes Mosquitoes and Aedes-Borne Arboviruses in Africa: Current and Future Threats. International Journal of Environmental Research and Public Health 2018, Vol 15, Page 220 [Internet]. 2018 Jan 28 [cited 2023 Jul 31];15(2):220. Available from: https://www.mdpi.com/1660-4601/15/2/220/htm
    OpenUrl
  90. 90.
    Espinal MA, Andrus JK, Jauregui B, Waterman SH, Morens DM, Santos JI, et al. Emerging and Reemerging Aedes-Transmitted Arbovirus Infections in the Region of the Americas: Implications for Health Policy. Am J Public Health [Internet]. 2019 [cited 2023 Aug 21];109(3):387. Available from: /pmc/articles/PMC6366516/
    OpenUrl
  91. 91.↵
    Kraemer MUG, Sinka ME, Duda KA, Mylne AQN, Shearer FM, Barker CM, et al. The global distribution of the arbovirus vectors Aedes aegypti and Ae. Albopictus. Elife. 2015 Jun 30;4(JUNE2015).
  92. 92.↵
    Balakrishnan VS. WHO launches global initiative for arboviral diseases. Lancet Microbe [Internet]. 2022 Jun 1 [cited 2024 Sep 5];3(6):e407. Available from: http://www.thelancet.com/article/S2666524722001306/fulltext
    OpenUrl
  93. 93.↵
    World Health Organization. Global vector control response 2017–2030. Geneva; 2017.
  94. 94.↵
    van den Berg H, Velayudhan R, Ejov M. Regional framework for surveillance and control of invasive mosquito vectors and re-emerging vector-borne diseases: 2014–2020. In: Regional framework for surveillance and control of invasive mosquito vectors and re-emerging vector-borne diseases: 2014–2020. 2013.
  95. 95.↵
    MOH. 3rd Edition IDSR Technical Guidelines. 2022.
  96. 96.↵
    Geteri F, Dawa J, Gachohi J, State W, Kenya U, Kadivane S, et al. A recent history of disease outbreaks in Kenya, 2007-2022: Findings from routine surveillance data. 2024 Mar 21 [cited 2024 Sep 6]; Available from: https://www.researchsquare.com
  97. 97.↵
    Kahariri S, Thumbi SM, Bett B, Mureithi MW, Nyaga N, Ogendo A, et al. The evolution of Kenya’s animal health surveillance system and its potential for efficient detection of zoonoses. Front Vet Sci [Internet]. 2024 [cited 2024 Sep 6];11:1379907. Available from: /pmc/articles/PMC11223174/
    OpenUrl
  98. 98.↵
    WHO. Surveillance and control of arboviral diseases in the WHO African Region assessment of country capacities. Geneva; 2022.
  99. 99.↵
    Biu PW, Nwasike CN, Tula OA, Ezeigweneme CA, Gidiagba JO, Biu PW, et al. A review of GIS applications in public health surveillance. https://wjarr.com/sites/default/files/WJARR-2023-2684.pdf [Internet]. 2024 Jan 30 [cited 2024 Sep 6];21(1):030–9. Available from: https://wjarr.com/content/review-gis-applications-public-health-surveillance
  100. 100.↵
    Vogels CBF, Rückert C, Cavany SM, Perkins TA, Ebel GD, Grubaugh ND. Arbovirus coinfection and co-transmission: A neglected public health concern? PLoS Biol [Internet]. 2019 [cited 2024 Oct 9];17(1). Available from: /pmc/articles/PMC6358106/
  101. 101.↵
    Varghese J, De Silva I, Millar DS. Latest Advances in Arbovirus Diagnostics. Microorganisms 2023, Vol 11, Page 1159 [Internet]. 2023 Apr 28 [cited 2024 Sep 5];11(5):1159. Available from: https://www.mdpi.com/2076-2607/11/5/1159/htm
    OpenUrl
  102. 102.↵
    Ng’ang’a PN, Aduogo P, Mutero CM. Strengthening community and stakeholder participation in the implementation of integrated vector management for malaria control in western Kenya: a case study. Malar J [Internet]. 2021 Dec 1 [cited 2024 Sep 6];20(1):1–14. Available from: https://malariajournal.biomedcentral.com/articles/10.1186/s12936-021-03692-4
    OpenUrlCrossRef
  103. 103.↵
    Mutero CM, Mbogo C, Mwangangi J, Imbahale S, Kibe L, Orindi B, et al. An Assessment of Participatory Integrated Vector Management for Malaria Control in Kenya. Environ Health Perspect [Internet]. 2015 Nov 1 [cited 2023 Aug 22];123(11):1145–51. Available from: https://ehp.niehs.nih.gov/doi/10.1289/ehp.1408748
    OpenUrl
  104. 104.↵
    Buchwald AG, Hayden MH, Dadzie SK, Paull SH, Carlton EJ. Aedes-borne disease outbreaks in West Africa: A call for enhanced surveillance. Acta Trop [Internet]. 2020 Sep 1 [cited 2024 Sep 5];209. Available from: https://pubmed.ncbi.nlm.nih.gov/32416077/
  105. 105.↵
    Dzul-Manzanilla F, Ibarra-López J, Marín WB, Martini-Jaimes A, Leyva JT, Correa-Morales F, et al. Indoor Resting Behavior of Aedes aegypti (Diptera: Culicidae) in Acapulco, Mexico. J Med Entomol [Internet]. 2017 Mar 1 [cited 2024 Sep 6];54(2):501–4. Available from: https://pubmed.ncbi.nlm.nih.gov/28011725/
    OpenUrl
  106. 106.↵
    WHO. Meeting of programme managers and the Regional Technical Advisory Group on dengue and other arboviruses in the South-East Asia Region. . New Delhi; 2024.
  107. 107.↵
    Zoonotic Disease Unit. National Contingency Plan for Rift Valley Fever. Nairobi; 2014.
  108. 108.↵
    Ng’etichi AKS, Voyi K, Kirinyet RC, Mutero CM. A systematic review on improving implementation of the revitalised integrated disease surveillance and response system in the African region: A health workers’ perspective. PLoS One [Internet]. 2021 Mar 1 [cited 2024 Sep 6];16(3). Available from: /pmc/articles/PMC7978283/
  109. 109.↵
    Wolfe CM, Hamblion EL, Dzotsi EK, Mboussou F, Eckerle I, Flahault A, et al. Systematic review of Integrated Disease Surveillance and Response (IDSR) implementation in the African region. PLoS One [Internet]. 2021 Feb 1 [cited 2024 Sep 6];16(2). Available from: /pmc/articles/PMC7906422/
Back to top
Posted October 18, 2024.
Download PDF

Supplementary Material

Data/Code
Email
Arboviruses in Kenya: A Systematic Review and Meta-analysis of Prevalence
Lynn J Kirwa, Hussein M. Abkallo, Richard Nyamota, Enock Kiprono, Dishon Muloi, James Akoko, Jennifer S. Lord, Bernard Bett
medRxiv 2024.10.17.24315511; doi: https://doi.org/10.1101/2024.10.17.24315511
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area